Study: FDG-PET/CT appears to help detect additional thyroid tumors

07/9/2013 |

In a study published in the Journal of Nuclear Medicine, FDG-PET/CT appeared to be effective in detecting differentiated thyroid carcinoma lesions that traditional protocols failed to identify. Researchers evaluated 18F-FDG-PET/CT findings in patients simultaneously receiving I-131 therapy and found additional tumors in up to 46% of the patients. "F-18 FDG PET/CT is useful for the detection of recurrent DTC lesions, especially in patients with iodine-negative tumors and elevated serum thyroglobulin levels," according to researchers.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Affairs Specialist
Becton Dickinson
Franklin Lakes, NJ
Customer Service Director
Minneapolis, MN
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Behavioral Health Operations Director
Minneapolis, MN
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID